Table 1.
Characteristic | Overall | Baseline |
P Valuea | Posttest |
P Valuea | ||
---|---|---|---|---|---|---|---|
Intervention (n = 353) | Control (n = 286) | Intervention (n = 339) | Control (n = 314) | ||||
Community | NA | NA | |||||
1 | 390 (30) | 228 (65) | 162 (48) | ||||
2 | 302 (23) | 125 (35) | 177 (52) | ||||
3 | 281 (22) | 136 (48) | 145 (46) | ||||
4 | 319 (25) | 150 (52) | 169 (54) | ||||
Social media site | .1 | .6 | |||||
1 | 457 (35) | 114 (32) | 110 (38) | 113 (33) | 120 (38) | ||
2 | 305 (24) | 80 (23) | 72 (25) | 83 (24) | 70 (22) | ||
3 | 397 (31) | 122 (35) | 75 (26) | 107 (32) | 93 (30) | ||
4 | 133 (10) | 37 (10) | 29 (10) | 36 (11) | 31 (10) | ||
Age, y | 40.9 ± 13.3 [18, 74] | 42.1 ± 14.5 [18, 70] | 42.9 ± 13.0 [18, 70] | .5 | 41.1 ± 12.7 [18, 65] | 37.4 ± 12.3 [18, 74] | .3 |
Sexual orientation | .4 | .03 | |||||
Gay | 657 (51) | 199 (56) | 162 (57) | 176 (52) | 120 (38) | ||
Bisexual | 465 (36) | 116 (33) | 81 (28) | 118 (35) | 150 (48) | ||
Straight | 162 (13) | 37 (10) | 42 (15) | 39 (12) | 44 (14) | ||
Other | 8 (<1) | 1 (<1) | 1 (<1) | 6 (2) | 0 | ||
Transgender identity | 28 (2.2) | 8 (2.3) | 7 (2.5) | .9 | 7 (2.1) | 6 (1.9) | .8 |
Race/ethnicityb | .05 | .01 | |||||
American Indian | 31 (2) | 13 (4) | 9 (3) | 5 (2) | 4 (1) | ||
African American/Black | 193 (15) | 44 (12) | 52 (18) | 60 (18) | 37 (12) | ||
Asian/Pacific Islander | 26 (2) | 14 (4) | 9 (3) | 2 (<1) | 1 (<1) | ||
Native Hawaiian | 43 (3) | 0 | 2 (<1) | 4 (1) | 37 (12) | ||
Latino | 69 (5) | 26 (7) | 31 (11) | 10 (3) | 2 (<1) | ||
White | 930 (72) | 256 (73) | 183 (64) | 258 (76) | 233 (74) | ||
Sex with men, past 12 mo | 1214 (94) | 338 (96) | 263 (92) | .05 | 317 (94) | 296 (94) | .7 |
Sex with men and women, past 12 mo | 421 (33) | 126 (36) | 99 (35) | .8 | 103 (30) | 93 (30) | .9 |
HIV positivec | 117 (9) | 19 (5) | 28 (10) | .06 | 43 (13) | 27 (9) | .2 |
New HIV positive infection, past 12 mo | 87 (6.7) | 15 (4) | 14 (5) | .5 | 41 (12) | 17 (5) | .04 |
Drunk in a typical weekd | 520 (40) | 101 (29) | 83 (29) | .8 | 169 (50) | 167 (53) | .6 |
Drug use, past 12 moa | |||||||
Tobacco | 419 (32) | 95 (27) | 90 (31) | .9 | 121 (36) | 113 (36) | .9 |
Marijuana | 18 (1) | 0 | 0 | NA | 8 (2) | 10 (3) | .5 |
Cocaine | 31 (2) | 16 (5) | 4 (1) | .7 | 7 (2) | 4 (1) | .4 |
Crack | 20 ( 2) | 16 (5) | 4 ( 1) | .7 | 0 | 0 | NA |
Alkyl nitrites (poppers) | 193 (15) | 49 (14) | 37 (13) | .6 | 49 (14) | 58 (18) | .2 |
Methamphetamine | 0 | 0 | 0 | NA | 0 | 0 | NA |
Ecstasy | 14 (1) | 0 | 0 | NA | 10 (3) | 4 (1) | .2 |
GHB | 0 | 0 | 0 | NA | 0 | 0 | NA |
Oxycodone | 10 (<1) | 0 | 0 | NA | 5 (1) | 5 (1) | .9 |
Viagra, Levitra, Cialis | 210 (16) | 65 (18) | 45 (16) | .9 | 49 (14) | 51 (16) | .9 |
Seen the health educator within any social media site | 348 (27) | 12 (3.0) | 9 (3.0) | .2 | 327 (96.5) | 6 (1.9) | <.01 |
Communicated with the health educator with any social media site | 299 (23) | 0 (0.0) | 2 (0.7) | .5 | 297 (88) | 0 (0) | <.01 |
Data are presented as No. (%) or mean ± SD [min, max].
Abbreviations: GHB, γ-hydroxybutyric acid; HIV, human immunodeficiency virus; NA, not available; SD, standard deviation.
a No significance testing performed due to low prevalence/nonconvergence.
b Grouped into African American/black, white, and other for significance testing.
c Of those reporting past 12-month HIV testing, positive vs negative differences tested for significance.
d Being drunk at least once in a typical week.